94 related articles for article (PubMed ID: 3826177)
1. Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations.
Sherwin BB; Gelfand MM; Schucher R; Gabor J
Am J Obstet Gynecol; 1987 Feb; 156(2):414-9. PubMed ID: 3826177
[TBL] [Abstract][Full Text] [Related]
2. The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women.
Cauley JA; Gutai JP; Kuller LH; Powell JG
Am J Epidemiol; 1990 Nov; 132(5):884-94. PubMed ID: 2239903
[TBL] [Abstract][Full Text] [Related]
3. Changes in lipids and lipoproteins with long-term estrogen deficiency and hormone replacement therapy.
Gambrell RD; Teran AZ
Am J Obstet Gynecol; 1991 Aug; 165(2):307-15; discussion 315-7. PubMed ID: 1872331
[TBL] [Abstract][Full Text] [Related]
4. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
5. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
[TBL] [Abstract][Full Text] [Related]
6. The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women.
Tadmor OP; Kleinman Y; Goldstein R; Diamant YZ
Int J Gynaecol Obstet; 1992 Oct; 39(2):105-10. PubMed ID: 1358708
[TBL] [Abstract][Full Text] [Related]
7. Prolonged effects of a novel, low-dosage continuous progestin-cyclic estrogen replacement program in postmenopausal women.
Plunkett ER; Wolfe BM
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):117-21. PubMed ID: 1733180
[TBL] [Abstract][Full Text] [Related]
8. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women.
Worsley R; Robinson PJ; Bell RJ; Moufarege A; Davis SR
Menopause; 2013 Jun; 20(6):640-5. PubMed ID: 23531683
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein metabolism in postmenopausal and oophorectomized women.
Wakatsuki A; Sagara Y
Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
12. Hepatic lipase activity during oral and parenteral 17 beta-estradiol replacement therapy: high-density lipoprotein increase may not be antiatherogenic.
Basdevant A; de Lignieres B; Simon P; Blache D; Ponsin G; Guy-Grand B
Fertil Steril; 1991 Jun; 55(6):1112-7. PubMed ID: 1903730
[TBL] [Abstract][Full Text] [Related]
13. The effect of hormone replacement therapy on metabolism of lipoprotein remnants in postmenopausal women.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Maturitas; 2000 Jan; 34(1):75-82. PubMed ID: 10687885
[TBL] [Abstract][Full Text] [Related]
14. Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy.
Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
Maturitas; 2004 Feb; 47(2):123-9. PubMed ID: 14757271
[TBL] [Abstract][Full Text] [Related]
15. Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men.
Bagatell CJ; Knopp RH; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1994 Apr; 78(4):855-61. PubMed ID: 8157711
[TBL] [Abstract][Full Text] [Related]
16. Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males.
Berglund L; Carlström K; Stege R; Gottlieb C; Eriksson M; Angelin B; Henriksson P
J Clin Endocrinol Metab; 1996 Jul; 81(7):2633-7. PubMed ID: 8675589
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
18. Effect on lipoproteins of Trisequens, a combined hormone preparation.
Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
[TBL] [Abstract][Full Text] [Related]
19. Lipid and lipoprotein levels following pure estradiol implantation in post-menopausal women.
Sharf M; Oettinger M; Lanir A; Kahana L; Yeshurun D
Gynecol Obstet Invest; 1985; 19(4):207-12. PubMed ID: 4029753
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
Gynecol Endocrinol; 2002 Apr; 16(2):155-62. PubMed ID: 12012627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
